Top news of the week: 15.12.2020.
Career And Jobs
Special report: Twenty extraordinary women blazing trails in biopharma R&D — Covid-19 and beyond
In the second year of Endpoints News' budding tradition of highlighting women blazing trails in biopharma R&D, we've seen a number of firsts. For the first time, the biggest story in R&D ...
Building Customer Awareness for the Next Biotech Startup: Lessons from Brands & Biology
How do you tell the story of clean meat, sustainable fashion, brewed buildings, carbon recyclables, consumer care, and skiing? The answer: through biology.
Be on the Cutting-Edge of Biotechnology with a Master’s Degree in Clinical Translation Management
There is a lot of complexity within the process of preparing treatments, medication and therapies for patient use. However, if you like a challenge, a career in translational management ...
Top 16 Highest-Paid Women CEOs in the Biopharma Industry
Female leaders in the biopharma industry may further promote diversity and inclusion at the workplace and serve as role models for young female professionals. Here is a list of 16 of the ...
Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review
SHANGHAI, Dec. 13, 2020 /PRNewswire/ -- Viva Biotech's Online Investor Day was successfully hosted on December 8, 2020. The management team conducted an online dialogue with nearly 400 ...
Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS
Results show continued efficacy of neratinib in patients with HER2-positive early stage breast cancerLOS ANGELES, Calif., December 11, 2020 / B3C newswire / -- Puma Biotechnology, Inc. ...
Ex-GSK immunology chief takes over oncolytic virus biotech Candel as it ramps up its pipeline
After at stint at Flagship Pioneering that was “one of the best experiences” in his career, Paul-Peter Tak, M.D., Ph.D., has a new gig. The former GlaxoSmithKline immunology chief takes ...
IPO Frenzy Continues as 4 More Go Public
Another four companies join the Nasdaq, bringing the life science IPO count to over 70 this year.